ICD 10 Coding Alert

Reader Question:

ICD-10 Anemia Guidelines in the Spotlight

Question: I read an article that said ICD-10 guidelines for anemia/neoplasm coding differ from ICD-9. Where can I access the ICD-10 guidelines?

Answer: You can download the 2010 ICD-10 guidelines from CMS's ICD-10 site: www.cms.gov/ICD10/12_2010_ICD_10_CM.asp. You also can download them from the CDC's ICD-10-CM site: www.cdc.gov/nchs/icd/icd10cm.htm#10update.

Remember: When ICD-10 goes into effect on Oct. 1, 2013, you will apply the official ICD-10 coding guidelines in effect for the relevant date of service.

The anemia/neoplasm differences that you refer to most likely relate to coding anemia associated with a malignancy (when the encounter is for the anemia) and coding adverse effects.

Neoplasm/anemia scenario: Suppose a patient has anemia associated with a malignancy, and she presents for treatment of the anemia only.

ICD-9: ICD-9 guidelines state that your first-listed code should be for anemia, 285.22 (Anemia in neoplastic disease). Then, the guidelines instruct you to report the appropriate malignancy code(s) (ICD-9, Section I.C.2.c.1, www.cdc.gov/nchs/data/icd9/icdguide10.pdf).

ICD-10: ICD-10 guidelines, on the other hand, instruct you that in the above scenario, you must report the malignancy first and then the anemia code, D63.0 (Anemia in neoplastic disease) (ICD-10, Section I.C.2.c.1).

Treatment/anemia scenario: Suppose a patient has anemia caused by his chemotherapy, immunotherapy, or radiotherapy, and he presents for treatment of the anemia only.

ICD-9: You should sequence the anemia first (such as 285.3, Antineoplastic chemotherapy induced anemia), according to ICD-9 guidelines. Then report the appropriate neoplasm code (ICD-9, Section I.C.2.c.2). In addition, when the patient has an adverse reaction to a correctly prescribed and administered substance, ICD-9 instructs you to code the reaction followed by a code from E930-E949 (ICD-9, Section I.C.19.c). For example, you might report E933.1 (Drugs, medicinal, and biological substances causing adverse effects in therapeutic use; antineoplastic and immunosuppressive drugs).

ICD-10: Your first-listed code should be an adverseeffect code, under ICD-10. Then report the anemia and neoplasm codes (ICD-10, Section I.C.2.c.2).

Bottom line: The ICD-10 change isn't just about new codes. Stay alert for changes to guidelines, as well. Get a head start by reading through the ICD-10 official guidelines that apply to the diagnoses you report most often. Consider highlighting differences in the logic and sequencing as you read through and compare for a more comprehensive understanding of important changes, especially for the codes you use most often for your specialty.

Other Articles in this issue of

ICD 10 Coding Alert

View All

Which Codify by AAPC tool is right for you?

Call 844-334-2816 to speak with a Codify by AAPC specialist now.